Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.4300
-0.0100 (-2.27%)
Jun 12, 2026, 1:38 PM AEST
Cambium Bio Market Cap
Cambium Bio has a market cap or net worth of 11.75 million as of June 12, 2026. Its market cap has increased by 58.88% in one year.
Market Cap
11.75M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.43
Market Cap Chart
Since April 5, 2024, Cambium Bio's market cap has increased from 7.97M to 11.75M, an increase of 47.51%. That is a compound annual growth rate of 19.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 11.75M | 8.87% |
| Dec 31, 2025 | 10.80M | 103.21% |
| Dec 31, 2024 | 5.31M | -33.33% |
| Apr 5, 2024 | 7.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 20.65M |
| Opthea | 19.15M |
| Neurotech International | 17.13M |
| Argenica Therapeutics | 16.70M |
| Immuron | 11.11M |
| AdAlta | 9.30M |
| Invex Therapeutics | 9.02M |
| Acrux | 8.73M |